コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d aspartate aminotransferase, AST) and total serum protein.
2 ted in the corresponding lysine of the human serum protein.
3 proteolysis when tethered to the long-lived serum protein.
4 alpha-trypsin inhibitor (IaI) is an abundant serum protein.
5 gen activator, plasminogen, or any prominent serum protein.
6 a model biomolecule against a background of serum protein.
7 otein at the level of 4.0 fmol of ospA/mg of serum protein.
8 tors assessed in splenic gene expression and serum proteins.
9 ed by correlating the skin transcriptome and serum proteins.
10 that these are ligands stabilizing the major serum proteins.
11 ce the production of abnormally glycosylated serum proteins.
12 the presence of high salt concentrations and serum proteins.
13 ell as in casein micelles separated from the serum proteins.
14 ies of more than two dozen membrane-bound or serum proteins.
15 onto live cell membranes in the presence of serum proteins.
16 to IFN-gamma in the presence of overabundant serum proteins.
17 ia, remains a mystery due to the plethora of serum proteins.
18 in factor H (FH) and additional unidentified serum proteins.
19 that some bacteria mask their surfaces with serum proteins.
20 n interaction through their interaction with serum proteins.
21 urement of the binding of small molecules to serum proteins.
22 g injury, such as surfactant, proteases, and serum proteins.
23 nes are adjacent and express closely related serum proteins.
24 citation, and asymptomatic elevations of two serum proteins.
25 to competitive adsorption of surface active serum proteins.
26 ficant interference from other cytokines and serum proteins.
27 were significantly altered as CBLG bound to serum proteins.
28 le resilience to the non-specific binding of serum proteins.
29 bs) not previously tested for cross-reacting serum proteins.
30 adsorption surface coverage of crude bovine serum proteins.
31 rs-of-magnitude lower than the most abundant serum proteins.
32 sensor surface with considerable amounts of serum proteins.
33 ell attachment and binding and inhibition of serum proteins.
34 ve been identified, including GDF-associated serum protein-1 (GASP-1) and GASP-2, which are capable o
35 growth and differentiation factor-associated serum protein-1) as a novel downstream target of PPARbet
37 protein adsorbers effectively competed with serum protein adsorbers for the hydroxyapatite surface.
38 icles to exhibit not only high resistance to serum protein adsorption but also pH-dependent adsorptio
41 e of size and surface chemistry in mediating serum protein adsorption to gold nanoparticles and their
46 e respiratory distress syndrome in which the serum protein albumin adsorbs to an air-liquid interface
48 transcriptional changes were induced by the serum protein albumin via TGFbeta signaling in primary a
49 f phospholipid-bound vesicles containing the serum proteins albumin, fetuin-A, and apolipoprotein A1;
51 mpared directly, 34 differentially expressed serum proteins allowed the separation of these two patie
52 albumin, constituting more than 50% of total serum proteins, allows increased protein loads on immobi
53 ugh it has previously been reported that the serum protein alpha(2)-macroglobulin is unable to inhibi
54 filing, provided insights into the nature of serum-protein alterations in pancreatic cancer patients,
55 sibly occurs as a result of competition with serum proteins, although our data seem to rule out a dir
57 irectly correlated with the intensity of the serum protein and indirectly with the tryptic peptides m
58 rognostic and predictive strategies based on serum protein and messenger RNA biomarkers can identify
59 tions and examined correlations between this serum protein and the antibiotic treatment outcomes of p
60 -specific binding to cells, interaction with serum proteins and cell adhesion molecules and can lead
61 ate analysis of these markers, together with serum proteins and cytokines, revealed a general signatu
62 ion, several co-linear relationships between serum proteins and DTI measures reported in healthy cont
64 sis of small molecules in samples containing serum proteins and for the measurement of the binding of
65 esis and storage of nutrients, production of serum proteins and hormones, and breakdown of toxins and
68 order to minimize nonspecific adsorption of serum proteins and other biomolecules, and (ii) a signal
70 unique interactions of FhbA with individual serum proteins and provide support for the hypothesis th
71 akdown associated with brain accumulation of serum proteins and several vasculotoxic and/or neurotoxi
73 presses an unexpected dependence of Nodal on serum proteins and that it is critically required for no
74 s are the major barrier to the filtration of serum proteins, and altered podocyte function and/or red
75 drug can enhance its half-life by binding to serum proteins, and be targeted to bacterial membranes.
77 ulation frequencies, cytokine responses, and serum proteins, and found that 77% of these are dominate
78 aphy, blocked blood-brain barrier leakage of serum proteins, and increased the number of endothelial
79 and mucin type O-glycosylation was found on serum proteins, and reduced metabolic labeling of sialic
80 ss the strength of association between these serum proteins, and to determine group sizes needed for
82 ealed significant binding of (177)Lu-cm09 to serum proteins ( approximately 91%) in plasma, compared
84 spectrometry, we find that over 70 different serum proteins are heterogeneously adsorbed to the surfa
87 ular the effect on this of the adsorption of serum proteins, are directly examined by measuring the f
89 on the use of the nonspecific adsorption of serum proteins as an additional layer of surface passiva
91 tient subgroups were performed to assess the serum proteins associated with anti-Jo-1 antibody-positi
92 1831 corresponded to approximately 100 known serum proteins, based on MS/MS analysis of one run each
93 ith collagen IV, fibronectin, laminin-332 or serum proteins before seeding with 125 mouse islets.
94 ogous to the target antigen of antiCl on the serum protein beta-2 glycoprotein-I (beta2GPI) and thus
95 Taken together, these data suggest that the serum protein beta2-GPI initiates the IR-induced intesti
98 evious studies indicated that binding of the serum protein, beta2-glycoprotein I, to the endothelium
99 roperties upon disassembly, we observed that serum proteins bind to and interact with the polymeric a
100 re, were employed to produce models of human serum protein binding (% bound) on a data set of 1008 ex
101 ide engineering strategy that incorporates a serum protein binding motif onto a covalent side-chain s
103 compromised targeting owing to non-specific serum protein binding, and hindered tumor penetration.
104 n of clinical, radiographic, functional, and serum protein biomarker assessments, this study was aime
105 strated that combinations of these and other serum protein biomarkers can distinguish these disease s
106 trometry (SELDI-TOF MS) to identify multiple serum protein biomarkers for detection of liver disease
110 to normalize the basal metabolic rate and/or serum protein-bound iodine level, but thyrotoxic adverse
111 ve been designed to limit steroid binding to serum proteins, but there is evidence that binding to se
112 ling of peptides has been measured for a few serum proteins, but this approach awaits full validation
113 his study, we report the prefractionation of serum proteins by batch anion exchange chromatography in
114 e proteins can be separated from the bulk of serum proteins by high-speed centrifugation causing subs
119 sis of changes in the heat capacity of blood serum proteins can provide an insight into patient respo
120 These data indicate that host and pathogen serum proteins can serve as reliable biomarkers for trac
121 ransduction occurs via an unidentified mouse serum protein capable of bridging HAdV-5 to CAR.IMPORTAN
123 Human breast cancer cells (MCF-7) grown on serum protein-coated gold sensors were placed in dynamic
124 rated that ERFE messenger RNA expression and serum protein concentration increase in mice subjected t
125 into the underlying genetic architecture of serum protein concentrations and their association with
126 repair of DNA strand breaks improves, as do serum protein concentrations that are associated with th
127 expression of olfactomedin-4 messenger RNA, serum protein concentrations, and percentage of neutroph
128 Many disorders are associated with altered serum protein concentrations, including malnutrition, ca
130 ter alpha inhibitor (IalphaI) is an abundant serum protein consisting of three polypeptides: two heav
131 the profiling of hepatic gene expression and serum protein content in patients with different subtype
132 nsideration to modulate the formation of the serum protein corona (PC) and the resultant immune respo
134 tration in particular, of T cells as well as serum proteins correlate with lupus disease activity.
135 scanning calorimetry (DSC) analysis of blood serum proteins could reveal the patient response to the
138 yelin status, lesion activity, astrocytosis, serum protein distribution, axonal area, and axonal loss
139 distributed, obstructed amines) rapidly bind serum proteins, diverse cells types in vitro, and endoth
143 (90%, 95% confidence interval, 74%-97%); by serum protein electrophoresis and/or immunofixation elec
144 erapeutic antibodies with immunofixation and serum protein electrophoresis assays may lead to underes
145 s of sFLC, SRM data was more consistent with serum protein electrophoresis than nephelometric data an
147 ve metabolic panel, vitamin B12 measurement, serum protein electrophoresis with immunofixation, fasti
148 of differential scanning calorimetry (DSC), serum protein electrophoresis, and free light chain assa
152 e S. epidermidis 0-47 or with biotin-labeled serum proteins eluted from the surface of bacteria grown
153 conclusion, although significant numbers of serum proteins emanate from the gingival sulcus, their a
154 FLD and NASH and demonstrates key changes in serum protein expression levels between control subjects
156 ions provide evidence that the uptake of the serum protein fetuin-A by VSMC is a key event in the inh
158 emoglobin could be completely substituted by serum proteins for the provision of amino-acids in vitel
160 spE paralogs bound factor H and unidentified serum proteins from a subset of animals, while OspF and
164 of the counterflow used with TGF to exclude serum proteins from the analysis channel while small mol
167 were the first to report that a bifunctional serum protein, Gas6, bridges envelope phosphatidylserine
168 Welding was associated with increases in serum protein, GPx, aconitase, TAS, and isoprostane leve
169 riteria (a ratio of pleural fluid protein to serum protein >0.5, a ratio of pleural fluid LDH to seru
170 comprehensive human plasma proteome, 5 of 11 serum proteins had a differential rank greater than 200.
175 ood colourant tartrazine with two homologous serum proteins, HSA and BSA, were investigated, employin
176 ce-response patterns were obtained from five serum proteins (human serum albumin, immunoglobulin G, t
180 actors, such as glucose, ascorbic acid human serum protein, immunoglobulin G, and immunoglobulin M),
181 lts suggest the potential benefit of using a serum protein in a non-covalent manner in conjunction wi
184 levels of 190 multiplex immunoassay profiled serum proteins in 149 schizophrenia patients and 198 mat
185 nstrated a robust overexpression of multiple serum proteins in SSc patients, particularly those with
186 onolayer reduces the nonspecific signal from serum proteins in such a manner that short exposure of t
187 , several CFH-binding proteins, and abundant serum proteins in the retinal pigmented epithelium (RPE)
188 ies have emphasized the likely role of human serum proteins in the transportation and accumulation of
191 evaluating the stabilizing effect of several serum proteins including albumin and immunoglobulin G.
192 g fever in North America, binds host-derived serum proteins including factor H (FH), plasminogen, and
193 nosis interactions were identified for eight serum proteins including Factor-VII[rs555212], Alpha-1-A
195 is subfamily of proteins degrade a number of serum proteins, including circulating complement, provid
197 g to the quantification of a large number of serum proteins, including those with an abundance of 10(
199 nt of heavy chains that are derived from the serum protein inter-alpha-inhibitor (IalphaI), a process
200 m absorption to secretion; increased leak of serum protein into the intestinal lumen; and altered tig
201 of brain microvascular disease is leakage of serum proteins into the brain extracellular space, in a
202 e leakage of a fluorescent tracer as well as serum proteins into the developing brain and reduced the
203 utrophilic inflammation, vascular leakage of serum proteins into the lung tissue, and exudation of pr
205 and selectivity over other sugars and human serum proteins is demonstrated as a proof of concept.
206 the interactions of nanoparticles (NPs) with serum proteins is necessary for the rational development
209 mmunoaffinity depletion of the most abundant serum proteins, isobaric tags for relative and absolute
210 minidase that removes sialic acid from human serum proteins; it is required for T.denticola to grow i
211 ins is greatly enhanced by two lipid-binding serum proteins known as lipopolysaccharide-binding prote
212 polymorphism and pSS and found an increased serum protein level of IL-12p70 in patients with pSS car
213 th mutant AAT mRNA in the liver and defected serum protein level were inhibited by 95%, whereas liver
215 or gene expression by RNA sequencing and for serum protein levels by Luminex and enzyme-linked immuno
220 ranslational application, S-glutathionylated serum proteins may be useful as biomarkers in individual
222 ofiling, measuring the concentrations of 182 serum proteins obtained from acute HAV- (18), HBV- (18),
223 icants is often affected by their binding to serum proteins, of which the most abundant in humans is
225 potency between compounds and the effects of serum proteins on the metabolic stability of compounds d
227 self-assembled monolayers and adsorption of serum protein onto the formed layer can be measured cont
229 tial biomarker candidates, we determined the serum proteins overlapping with the retinal proteins kno
230 oresis/mass spectrometry identified specific serum proteins oxidized under cardiotoxic conditions.
231 L-13 as potential upstream regulators of the serum protein patterns in the sera of patients with diff
235 Transthyretin (TTR) is a largely beta-sheet serum protein responsible for transporting thyroxine and
241 s spiked into the complex matrix of digested serum protein solution where ion suppression effects and
245 they also degrade via removal of the iron by serum proteins, such as transferrin, over a period of se
246 ER-B with proteomic techniques allowed human serum proteins susceptible to oxidative damage to be det
247 ve protein (CRP) is a classical, acute phase serum protein synthesized by the liver in response to in
250 ing history, centre, and masked pretreatment serum protein test classification, and randomly assigned
252 ighly induced protein was DPP4, a measurable serum protein that has well-described roles in cancer pr
253 th the sera of mice deficient in fetuin-A, a serum protein that inhibits calcification, and the sera
254 annose-binding lectin (MBL) is a circulating serum protein that is sequestered to sites of inflammati
256 etween RBP4 and transthyretin (TTR), another serum protein that protects RBP4 from renal clearance.
259 sorption of albumin and other surface-active serum proteins that are present in the lung during acute
260 e studied the identity and quantity of human serum proteins that bind to spherical nucleic acid (SNA)
261 urfaces close to the gingival sulcus contact serum proteins that emanate via this sulcus, which may i
262 kidney mineral nanoparticles contain several serum proteins that inhibit ectopic calcification in bod
263 ctor H-like protein 1 (FH/FHL-1) are soluble serum proteins that negatively regulate the alternative
264 -based proteomics analyses, we identified 24 serum proteins that were significantly variant between t
266 Our goal was to identify a combination of serum proteins that would provide a biological measure f
268 tion of the capacity for a large, endogenous serum protein to gain unobstructed access to the transie
269 t sufficiently distinguish between these two serum proteins to allow it to hijack the regulator alone
270 n caused many of the differentially abundant serum proteins to be restored towards wild-type levels.
271 dhesion of human endothelial cells and human serum proteins to bioceramics of different compositions,
272 (SDS) denaturation and chemical reduction of serum proteins to dissociate ADA-drug bindings, followed
275 and Bruch's membrane and, together with the serum proteins transferrin and albumin, elevated in BM/C
276 n and partial monomer unfolding of the human serum protein transthyretin, resulting in aggregation an
277 weight loss along with serum levels of total serum protein (TSP), albumin, C-reactive protein, and le
280 yses were conducted for adiponectin mRNA and serum protein using a maximum likelihood-based variance
281 imization of the nonspecific signal from the serum protein was achieved by immobilizing the antibody
283 selectivity for venomous PLA2 over abundant serum proteins, was not cytotoxic, and showed substantia
284 rom several glycoprotein standards and human serum proteins, we demonstrated that the Y1 ion triggere
285 affinities of linear PFOS and PFOA to total serum protein were confirmed when both calf serum and hu
286 and a second membrane strip containing human serum proteins were coincubated with a ssDNA library con
292 xpression levels of 7 IRGs and IFN-inducible serum proteins were monitored as potential biomarkers fo
293 tive and integrin-selective binding of human serum proteins, whereas the binding and adhesion of huma
294 ral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic d
295 C-reactive protein (CRP) is an acute-phase serum protein with binding reactivity to nuclear autoant
296 of the patients, we identified a monoclonal serum protein with the same heavy- and light-chain isoty
297 etry-based approach we identified over 1,700 serum proteins with a peptide identification (ID) confid
298 arrays to probe the associations of multiple serum proteins with pancreatic cancer and to explore the
299 ment of either human serum or isolated human serum proteins with various oxidizing agents, damaged, b
300 FEPR = [serum creatinine x urine protein] / [serum protein x urine creatinine], %) and PCR ([urinary
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。